OBJECTIVEdTo evaluate the usefulness of a fasting plasma glucose (FPG) at 24-28 weeks' gestation to screen for gestational diabetes mellitus (GDM).
I
n 2011, the Ministry of Health (MOH) in China published the diagnostic criteria for gestational diabetes mellitus (GDM) based on a 75-g oral glucose tolerance test (OGTT) carried out between 24 and 28 weeks' gestation (1) . As a formal glucose tolerance test may be difficult to implement in low-resource rural areas in China, the MOH sought to assess whether a fasting plasma glucose (FPG) could be used as a screening tool to reduce the number of OGTTs required. The following cut points were suggested: if FPG $5.1 mmol/L, GDM can be diagnosed immediately; if FPG ,4.4 mmol/L, GDM can be considered unlikely. Thus, the 75-g OGTT only needs to be performed for women with FPG values $4.4 mmol/L and ,5.1 mmol/L. As there was no scientific evidence from China to support this approach, we conducted this study to test the hypothesis.
RESEARCH DESIGN AND
METHODSdDuring the past year, multiprofessional teams from 15 hospitals in different provinces of China were trained in screening, diagnosing, and providing care for women with GDM and to implement the new diagnostic standard (one-step approach). Pregnant women with previously known diabetes were excluded. RESULTSdROC curves to test the value of FPG at 24-28 weeks to diagnose GDM were created. The area under the ROC curve was 0.836 (95% CI 0.829-0.843), SE 0.004, P , 0.001. At 24-28 weeks, GDM diagnosis rate increased with rising FPG value, and at values .5.1 mmol/L all women with GDM (12.1%) were identified. As shown in Table 1 CONCLUSIONSdGDM is one of the common medical conditions associated with pregnancy with potentially serious health consequences for mother and offspring both in the short and long term (2-7). To address the problem, the MOH in China established guidelines and one-step diagnostic criteria for GDM based on the 75-g OGTT done at 24-28 weeks of gestation. Many poorly resourced facilities in China, particularly in small towns and rural areas, are unable to implement these guidelines. Therefore, a simple screening test and protocol to identify women who might need the 75-g OGTT would be extremely useful.
Our study shows that FPG value at 24-28 weeks' gestation can help decide whether the 75-g OGTT is needed. In Chinese women with FPG value $5.1 mmol/L, one can make the diagnosis of GDM (specificity 100%) and, in those with value #4.4 mmol/L one can rule out GDM (87.8% sensitivity). These results are similar to those reported by Agarwal et al. (8) in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort. In the HAPO study, risks of some adverse outcomes were low when FPG was 4.4 mmol/L (9). Considering these and efficiency, we conclude that FPG value of 4.4 mmol/L should be used as the optimal cut point. Women with FPG values between 4.4 and 5.1 mmol/L require a 75-g 2-h OGTT to confirm or rule out GDM. This strategy will reduce the number of OGTTs by about half (50.3%). These data are from China, and the results may only be applicable to a Chinese population, although the United Arab Emirates population studies also suggest the same cutoff points (10). care.diabetesjournals.org DIABETES CARE, VOLUME 36, JULY 2013 2039
